Clinical Report: Estriol may ease menopause-related cognitive decline
Overview
A case series involving 20 menopausal women indicated that estriol-based hormone treatment may improve cognitive symptoms over 12 months. Statistically significant improvements were observed across multiple cognitive domains, although the study lacked a control group and randomization.
Background
Cognitive decline during menopause is a significant concern for many women, impacting quality of life and daily functioning. Hormonal changes associated with menopause can lead to various cognitive symptoms, and understanding potential treatments is crucial for managing these effects. This study explores the role of estriol, a form of estrogen, in alleviating cognitive decline in menopausal women.
Data Highlights
| Parameter | Results |
|---|---|
| Participants | 20 menopausal women |
| Mean Age | 53.5 years |
| Estriol Doses | 2 mg (n=10), 4 mg (n=7), 8 mg (n=3) |
| Progesterone Doses | 100 mg (n=15), 200 mg (n=2), 0 mg (n=3) |
| Cognitive Domains Assessed | 6 (brain fog, concentration, working memory, processing speed, verbal memory, problem solving) |
| Improvement | Statistically significant across all domains |
Key Findings
- 20 menopausal women reported cognitive improvements after 12 months of estriol treatment.
- Statistically significant enhancements were observed in all assessed cognitive domains.
- Subgroup analyses showed improvements across various demographics without significant differences in outcomes.
- Preclinical studies in mice indicated estriol may reduce cognitive deficits and glial activation.
- Estrogen receptor beta signaling in astrocytes may play a role in cognitive effects of estriol.
- The study's limitations include lack of randomization and reliance on self-reported cognitive symptoms.
Clinical Implications
Clinicians should consider the limitations of this study when discussing treatment options with patients.
Conclusion
This preliminary study indicates that estriol-based treatment warrants further investigation for cognitive symptoms associated with menopause.
Related Resources & Content
- Noriko Itoh et al., Scientific Reports, 2023 -- Estriol may ease menopause-related cognitive decline
- MDSpire News — Menopause: New Target May Prevent Cognitive Decline
- MDSpire News — Menopause Treatment Shows No Brain Effects After Decade
- MDSpire News — More Menopause Symptoms, Greater Cognitive Risk
- MDSpire News — Menopause: More Cognitive Complaints, Not Decline
- Menopause: New Target May Prevent Cognitive Decline
- Menopause Treatment Shows No Brain Effects After Decade
- More Menopause Symptoms, Greater Cognitive Risk
- European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause
- Postmenopausal Hormone Therapy and Cognitive Outcomes: the Women's Health Initiative Memory Study (WHIMS)
- Menopause | FDA
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
